Bacterial safety of flash-heated and unheated expressed breastmilk during storage

Journal of Tropical Pediatrics

Volumn 52, Issue 6, 2006, Pages 399-405

  Israel Ballard, Kiersten A ^a   Coutsoudis, A ^b   Chantry, C J ^c   Sturm, A W ^b   Karim, F ^b   Sibeko, L ^d   Abrams, B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE;

ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BREAST MILK; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; FOOD SAFETY; FOOD STORAGE; GROWTH INHIBITION; HEATING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INFANT; MATERNAL DISEASE; PLATING MEDIUM; ROOM TEMPERATURE; SOUTH AFRICA; STAPHYLOCOCCUS AUREUS; STORAGE TEMPERATURE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A;

COLONY COUNT, MICROBIAL; DEVELOPING COUNTRIES; DISEASE TRANSMISSION, VERTICAL; ESCHERICHIA COLI; FEMALE; HEAT; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; NUTRITIVE VALUE; SOUTH AFRICA; STAPHYLOCOCCUS AUREUS; STERILIZATION; STREPTOCOCCUS;

EID: 33845718111     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fml043     Document Type: Article

References (54)

1. UNAIDS/WHO. AIDS epidemic update. UNAIDS/05.19E. Geneva: UNAIDS, 2005.
2. De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. JAMA 2000;283:1175-82.
3. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
4. Bahl R, Frost C, Kirkwood BR, et al. Infant feeding patterns and risks of death and hospitalization in the first half of infancy: Multicentre cohort study. Bull World Health Organ 2005;83:418-26.
5. Jones G, Steketee RW, Black RE, et al. And the Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet 2003;362:65-71.
6. Coutsoudis A. Breastfeeding and the HIV positive mother: The debate continues. Early Hum Dev 2005;81:87-93.
7. Coutsoudis A, Goga AE, Rollins N, et al. Free formula milk for infants of HIV-infected women: Blessing or curse? Health Policy Plan 2002;17:154-60.
8. Victora CG, Smith PG, Vaughan JP, et al. Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet 1987;2:319-22.
9. WHO, UNICEF, UNAIDS, UNFPA. HIV and infant feeding: A guide for health-care managers and supervisors. Geneva, Switzerland: WHO, 2004.
10. WHO, UNICEF, USAID et al. HIV and infant feeding: A question and answer guide for counselors, 2005.
11. Israel-Ballard K, Chantry C, Dewey K, et al. Viral, nutritional, and bacterial safety of Flash-heated and Pretoria-Pasteurized breast milk to prevent mother-to-child transmission of HIV in resource-poor countries: a pilot study. J Acquir Immune Defic Syndr 2005;40:175-81.
12. Israel-Ballard K, Donovan R, Chantry C, et al. Viral safety of flash-heated breast milk as an infant feeding option for HIV positive mothers in developing countries. Oral Presentation at XVI International Aids Conference 2006, Toronto, Canada.
13. Ajusi JD, Onyango FE, Mutanda LN, et al. Bacteriology of unheated expressed breast milk stored at room temperature. East Afr Med J 1989;66:381-7.
14. Ng DK, Lee SY, Leung LC, et al. Bacteriological screening of expressed breast milk revealed a high rate of bacterial contamination in Chinese women. J Hosp Infect 2004;58:146-50.
15. Narayanan I, Prakash K, Gujral VV. Management of expressed human milk in a developing country-experiences and practical guidelines. J Trop Pediatr 1982;28:25-8.
16. Liebhaber M, Lewiston NJ, Asquith MT, et al. Comparison of bacterial contamination with two methods of human milk collection. J Pediatr 1978;92:236-7.
17. Boo NY, Nordiah AJ, Alfizah H, et al. Contamination of breast milk obtained by manual expression and breast pumps in mothers of very low birthweight infants. J Hosp Infect 2001;49:274-81.
18. Lawrence R, Lawrence R. Breastfeeding: A Guide for the Medical Profession 5th edn. St Louis: Mosby, Inc., 1999.
19. Jeffery BS, Soma-Pillay P, Moolman G. The effect of Pretoria pasteurization on bacterial contamination of hand-expressed human breastmilk. J Trop Pediatr 2003;49:240-4.
20. Nwankwo MU, Offor E, Okolo AA, et al. Bacterial growth in expressed breast-milk. Ann Trop Paediatr 1988;8:92-5.
21. Ogundele MO. Techniques for the storage of human breast milk: implications for anti-microbial functions and safety of stored milk. Eur J Pediatr 2000;159:793-7.
22. Chen HY, Allen JC. Human milk antibacterial factors: The effect of temperature on defense systems. Adv Exp Med Biol 2001;501:341-8.
23. Pardou A, Serruys E, Mascart-Lemone F, et al. Human milk banking: influence of storage processes and of bacterial contamination on some milk constituents. Biol Neonate 1994;65:302-9.
24. Jones CL, Jennison RF, D'Souza SW. Bacterial contamination of expressed breast milk. Br Med J 1979;2:1320-2.
25. Sakaguchi M, Tomomasa T, Kuroume T. Cytolytic action of stored human milk on blood cells in vitro. J Perinat Med 1995;23:293-300.
26. Ogundele MO. Complement-mediated bactericidal activity of human milk to a serum-susceptible strain of E. coli 0111. J Appl Microbiol 1999;87:689-96.
27. Ogundele MO. Cytotoxicity by stored human breastmilk: Possible contribution of complement system. Cell Biol Int 1999;23:585-8.
28. Lavine M, Clark RM. Changing patterns of free fatty acids in breast milk during storage. J Pediatr Gastroenterol Nutr 1987;6:769-74.
29. U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration. Grade "A" pasteurized milk ordinance. Public Health Bulletin 220; 2003.
30. Lonnerdal B. Biochemistry and physiological function of human milk proteins. Am J Clin Nutr 1985;42:1299-317.
31. Coppa GV, Zampini L, Galeazzi T, et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 2006;59:377-82.
32. Georgeson JC, Filteau SM. Physiology, immunology, and disease transmission in human breast milk. AIDS Patient Care STDS 2000;14:533-9.
33. Noguera-Obenza M, Ochoa TJ, Gomez HF, et al. Human milk secretory antibodies against attaching and effacing Escherichia coli antigens. Emerg Infect Dis 2003;9:545-51.
34. Van de Perre P. Transfer of antibody via mother's milk. Vaccine 2003;21:3374-6.
35. Boesman-Finkelstein M, Finkelstein RA. Sequential purification of lactoferrin, lysozyme and secretory immunoglobulin A from human milk. FEBS Lett 1982;144:1-5.
36. Goldman AS. The immune system of human milk: Antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J 1993;12:664-71.
37. Rainard P. Bacteriostatic activity of bovine milk lactoferrin against mastitic bacteria. Vet Microbiol 1986;11:387-92.
38. Ellison RT, 3rd, Giehl TJ. Killing of gram-negative bacteria by lactoferrin and lysozyme. J Clin Invest 1991;88:1080-91.
39. Spik G, Cheron A, Montreuil J, et al. Bacteriostasis of a milk-sensitive strain of Escherichia coli by immunoglobulins and iron-binding proteins in association. Immunology 1978;35:663-71.
40. Tomita M, Bellamy W, Takase M, et al. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J Dairy Sci 1991;74:4137-42.
41. Edde L, Hipolito RB, Hwang FF, et al. Lactoferrin protects neonatal rats from gut-related systemic infection. Am J Physiol Gastrointest Liver Physiol 2001;281:G1140-50.
42. Steijns JM, van Hooijdonk AC. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. Br J Nutr 2000;84(Suppl 1):S11-7.
43. Harmsen MC, Swart PJ, de Bethune MP, et al. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 1995;172:380-8.
44. Andersson Y, Lindquist S, Lagerqvist C, et al. Lactoferrin is responsible for the fungistatic effect of human milk. Early Hum Dev 2000;59:95-105.
45. Hernandez J, Lemons P, Lemons J, et al. Effect of storage processes on the bacterial growth-inhibiting activity of human breast milk. Pediatrics 1979;63:597-601.
46. Heikkila MP, Saris PE. Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol 2003;95:471-8.
47. Hernell O, Olivecrona T. Human milk lipases. II. Bile salt-stimulated lipase. Biochim Biophys Acta 1974;369:234-44.
48. Ford JE, Law BA, Marshall VM, el al. Influence of the heat treatment of human milk on some of its protective constituents. J Pediatr 1977;90:29-35.
49. Van Zoeren-Grobben D, Schrijver J, Van den Berg H, et al. Human milk vitamin content after pasteurisation, storage, or tube feeding. Arch Dis Child 1987;62:161-5.
50. Bjorksten B, Burman LG, De Chateau P, et al. Collecting and banking human milk: To heat or not to heat? Br Med J 1980;281:765-9.
51. Goldblum RM, Dill CW, Albrecht TB, et al. Rapid high-temperature treatment of human milk. J Pediatr 1984;104:380-5.
52. Morgan JN, Lin FJ, Eitenmiller RR, et al. Thermal destruction of Eschericihia coli and Klebsiella pneumoniae in human milk. J Food Pro 1988;51:132-6.
53. Dhar J, Fichtali J, Skura BJ. Pasteurization Efficiency of a HTST System for Human Milk. J Food Sci 1996;61:569-73.
54. Guidelines for the establishment and operation of human milk banks in the UK. 3rd edn. United Kingdom Association for Milk Banking, London, England, 2003.